Variant report
Variant | nsv882499 |
---|---|
Chromosome Location | chr5:101125653-101191593 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:55)
- CpG islands (count:0)
- Chromatin interactive region (count:3)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | CEBPB | chr5:101165091-101165242 | K562 | blood: | n/a | n/a |
2 | CEBPB | chr5:101142779-101143049 | HepG2 | liver: | n/a | chr5:101142918-101142929 |
3 | CEBPB | chr5:101142819-101143071 | A549 | lung: | n/a | chr5:101142918-101142929 |
4 | CEBPB | chr5:101165030-101165279 | A549 | lung: | n/a | n/a |
5 | CEBPB | chr5:101127405-101127502 | HepG2 | liver: | n/a | chr5:101127458-101127469 |
6 | CTCF | chr5:101152280-101152430 | GM12866 | blood: | n/a | n/a |
7 | CTCF | chr5:101136171-101136274 | GM20000 | blood: | n/a | n/a |
8 | CTCF | chr5:101128950-101128982 | ProgFib | skin: | n/a | n/a |
9 | E2F4 | chr5:101139776-101140191 | MCF10A-Er-Src | breast: | n/a | n/a |
10 | E2F4 | chr5:101131625-101131650 | MCF10A-Er-Src | breast: | n/a | n/a |
11 | FOS | chr5:101132338-101132478 | MCF10A-Er-Src | breast: | n/a | n/a |
12 | GATA3 | chr5:101152103-101152277 | SH-SY5Y | brain: | n/a | n/a |
13 | JUN | chr5:101163464-101163625 | K562 | blood: | n/a | n/a |
14 | JUND | chr5:101147619-101147681 | H1-hESC | embryonic stem cell: | n/a | n/a |
15 | KAP1 | chr5:101161540-101161848 | K562 | blood: | n/a | n/a |
16 | KAP1 | chr5:101179612-101179812 | K562 | blood: | n/a | n/a |
17 | KAP1 | chr5:101165450-101166023 | K562 | blood: | n/a | n/a |
18 | MAFK | chr5:101149556-101149682 | HepG2 | liver: | n/a | n/a |
19 | MYC | chr5:101129165-101129200 | GM12878 | blood: | n/a | n/a |
20 | MYC | chr5:101143307-101143379 | MCF-7 | breast: | n/a | n/a |
21 | MYC | chr5:101143300-101143368 | MCF-7 | breast: | n/a | n/a |
22 | MYC | chr5:101143258-101143372 | MCF-7 | breast: | n/a | n/a |
23 | POLR2A | chr5:101143173-101143478 | MCF-7 | breast: | n/a | n/a |
24 | POLR2A | chr5:101137784-101138125 | MCF10A-Er-Src | breast: | n/a | n/a |
25 | POLR2A | chr5:101166193-101166389 | MCF10A-Er-Src | breast: | n/a | n/a |
26 | POLR2A | chr5:101143348-101143451 | Gliobla | brain: | n/a | n/a |
27 | POLR2A | chr5:101149976-101150101 | MCF10A-Er-Src | breast: | n/a | n/a |
28 | POLR2A | chr5:101163935-101164110 | MCF10A-Er-Src | breast: | n/a | n/a |
29 | POLR2A | chr5:101142181-101142201 | MCF-7 | breast: | n/a | n/a |
30 | POLR2A | chr5:101181805-101181989 | MCF10A-Er-Src | breast: | n/a | n/a |
31 | POLR2A | chr5:101179960-101180035 | MCF10A-Er-Src | breast: | n/a | n/a |
32 | POLR2A | chr5:101142496-101142499 | MCF-7 | breast: | n/a | n/a |
33 | POLR2A | chr5:101142510-101142518 | MCF-7 | breast: | n/a | n/a |
34 | POLR2A | chr5:101135124-101135214 | GM12878 | blood: | n/a | n/a |
35 | POLR2A | chr5:101142371-101142464 | MCF-7 | breast: | n/a | n/a |
36 | POLR2A | chr5:101143307-101143411 | MCF-7 | breast: | n/a | n/a |
37 | POLR2A | chr5:101142436-101142480 | MCF-7 | breast: | n/a | n/a |
38 | POLR2A | chr5:101142480-101142508 | A549 | lung: | n/a | n/a |
39 | POLR2A | chr5:101142516-101142553 | A549 | lung: | n/a | n/a |
40 | POLR2A | chr5:101155133-101155220 | GM12878 | blood: | n/a | n/a |
41 | POLR2A | chr5:101126975-101127078 | MCF10A-Er-Src | breast: | n/a | n/a |
42 | POLR2A | chr5:101162226-101162363 | MCF10A-Er-Src | breast: | n/a | n/a |
43 | POLR2A | chr5:101143481-101143489 | MCF-7 | breast: | n/a | n/a |
44 | POLR2A | chr5:101143357-101143437 | A549 | lung: | n/a | n/a |
45 | POLR2A | chr5:101143441-101143453 | A549 | lung: | n/a | n/a |
46 | POLR2A | chr5:101168421-101168463 | MCF10A-Er-Src | breast: | n/a | n/a |
47 | RAD21 | chr5:101178459-101178776 | H1-hESC | embryonic stem cell: | n/a | n/a |
48 | RFX5 | chr5:101177287-101177344 | K562 | blood: | n/a | n/a |
49 | RFX5 | chr5:101157827-101157946 | K562 | blood: | n/a | n/a |
50 | STAT3 | chr5:101157662-101157934 | MCF10A-Er-Src | breast: | n/a | n/a |
No data |
(count:3 , 50 per page) page:
1
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
OR7H2P | TF binding region |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs138775152 | chr5:101130933-101130934 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs73176581 | chr5:101130937-101130938 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
3 | rs571860700 | chr5:101130972-101130973 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs116582921 | chr5:101130973-101130974 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs557207605 | chr5:101131056-101131057 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs60489585 | chr5:101131092-101131093 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
7 | rs71500619 | chr5:101131118-101131119 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
8 | rs529312428 | chr5:101131119-101131120 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs10064408 | chr5:101131128-101131129 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
10 | rs573244342 | chr5:101131148-101131149 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs540064541 | chr5:101131153-101131154 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs188192326 | chr5:101131158-101131159 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs532326987 | chr5:101131164-101131165 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs76124064 | chr5:101131169-101131170 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs192757418 | chr5:101131219-101131220 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs4703190 | chr5:101131228-101131229 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
17 | rs373184595 | chr5:101131247-101131248 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs386404572 | chr5:101131248-101131249 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs57158519 | chr5:101131258-101131259 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs79106141 | chr5:101131259-101131260 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs376961597 | chr5:101131288-101131289 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs59845776 | chr5:101131347-101131348 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
23 | rs145262821 | chr5:101131376-101131377 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs527344047 | chr5:101131381-101131382 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs546896411 | chr5:101131398-101131399 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs354673 | chr5:101131401-101131402 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs538838940 | chr5:101131464-101131465 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs557274850 | chr5:101131574-101131575 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs137861002 | chr5:101131584-101131585 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs4703191 | chr5:101131600-101131601 | Active TSS Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
31 | rs554503028 | chr5:101131609-101131610 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs573272068 | chr5:101131686-101131687 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs558422711 | chr5:101131687-101131688 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs540695283 | chr5:101131703-101131704 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs111935732 | chr5:101131726-101131727 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs188431657 | chr5:101131728-101131729 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs554942291 | chr5:101131760-101131761 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs142461097 | chr5:101131865-101131866 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs354674 | chr5:101131886-101131887 | Active TSS Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
40 | rs574744175 | chr5:101131909-101131910 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs73176586 | chr5:101131917-101131918 | Active TSS Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
42 | rs77701129 | chr5:101131945-101131946 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs191449601 | chr5:101131956-101131957 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs573771525 | chr5:101131957-101131958 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs552280798 | chr5:101131963-101131964 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs564019566 | chr5:101131968-101131969 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs532789103 | chr5:101131976-101131977 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs7701413 | chr5:101132030-101132031 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
49 | rs200844504 | chr5:101132048-101132049 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs569221517 | chr5:101132084-101132085 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Malaria | 21533027 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Cancer | 20164919 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Cancer | 16751803 | CNVD |
Intellectual disability | 22102821 | CNVD |
Breast cancer | 17603634 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Melanoma | 18172304 | CNVD |
Glioma | 20126413 | CNVD |
Breast cancer | 17393978 | CNVD |
Cancer | 21359685 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
adenomatous polyposis | 22470819 | CNVD |
Cancer | 22429812 | CNVD |
Cancer | 21637783 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Liposarcoma | 21253554 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Breast cancer | 21858162 | CNVD |
Leukemia | 17361228 | CNVD |
Myelodysplastic syndrome | 18508791 | CNVD |
5q-syndrome | 17576883 | CNVD |
Gastric cancer | 17908304 | CNVD |
Lung cancer | 16740712 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Esophageal adenocarcinoma | 19417022 | CNVD |
Barrett''s syndrome | 19417022 | CNVD |
Lung cancer | 18438408 | CNVD |
Retinoblastoma | 22278416 | CNVD |
Bipolar disorder | 18458673 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Breast cancer | 21785460 | CNVD |
Merkel cell carcinoma | 19020549 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
Prostate cancer | 18632612 | CNVD |
Breast cancer | 17133270 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Testicular cancer | 18059402 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Prostate cancer | 16573809 | CNVD |
Renal cell carcinoma | 18194544 | CNVD |
Chronic lymphocytic leukemia | 20421269 | CNVD |
Cancer | 20164920 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
abnormal development | 18461090 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Colorectal cancer | 16774939 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Chronic lymphocytic leukemia | 18922857 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Prostate cancer | 16461572 | CNVD |
Neurocytoma | 17123091 | CNVD |
Salivary gland tumor | 18059337 | CNVD |
Bipolar disorder | 19114987 | CNVD |
Breast cancer | 21509527 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr5:101130800-101131400 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
2 | chr5:101131400-101132000 | Active TSS | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
3 | chr5:101131400-101132200 | Enhancers | Monocytes-CD14+_RO01746 | blood |
4 | chr5:101131400-101132800 | Enhancers | Primary monocytes fromperipheralblood | blood |
5 | chr5:101132000-101132400 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
6 | chr5:101132200-101132600 | Flanking Active TSS | Monocytes-CD14+_RO01746 | blood |
7 | chr5:101132600-101133000 | Enhancers | Monocytes-CD14+_RO01746 | blood |
8 | chr5:101142400-101142600 | ZNF genes & repeats | iPS DF 19.11 Cell Line | embryonic stem cell |
9 | chr5:101172600-101174600 | Enhancers | Fetal Heart | heart |
10 | chr5:101173400-101174600 | Enhancers | Fetal Brain Male | brain |
11 | chr5:101173600-101174800 | Enhancers | Fetal Lung | lung |
12 | chr5:101174000-101174600 | Enhancers | Ganglion Eminence derived primary cultured neurospheres | brain |
13 | chr5:101174200-101174600 | Enhancers | Aorta | Aorta |
14 | chr5:101182200-101182600 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |